A Study of BAY3427080 (NT-814) in the Treatment of Moderate to Severe Post-menopausal Vasomotor Symptoms

NCT03596762 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

199

Enrollment

INDUSTRY

Sponsor class

Conditions

Menopause
Hot Flashes
Night Waking

Interventions

DRUG: Elinzanetant (BAY3427080)
DRUG: Placebo

Sponsor

Bayer

Collaborators

[object Object]